CANF

Can-Fite Biopharma Ltd ADR

$4.14

-0.22 (-5.05%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 10.01.2026
$3.50
(-15.46%)
Strong Buy: 0
Buy: 3
Hold: 0
Sell: 0
Strong Sell: 0
Description:
Can-Fite BioPharma Ltd. (CANF), based in Petah-Tikva, Israel, is a forward-looking clinical-stage biopharmaceutical company dedicated to the development of small molecule therapeutics aimed at serious diseases such as cancer, liver disorders, inflammatory conditions, COVID-19, and erectile dysfunction. The company's promising pipeline is supported by ongoing clinical trials that seek to meet significant unmet medical needs with its proprietary drug candidates. Utilizing a unique technology platform, Can-Fite capitalizes on the distinct mechanisms of action of its compounds, positioning the company as an emerging player with the potential to transform treatment paradigms in the biopharmaceutical sector.
Exchange:
NYSE MKT
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
26 BEN GURION STREET, RAMAT GAN, ISRAEL, 5257346
Fiscal year end:
December
Market capitalization:
$15.2 Million
EBITDA:
-$8.91 Million
PERatio:
0.0
EPS:
0.0
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
0.042

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-100%
How much will you get:
$0
Prices dates:
31-12-2015: $438.00 and 31-12-2025: $0.20